Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
Svenja Müller, Laura Maintz, Thomas Bieber
Allergy (2024) Vol. 79, Iss. 6, pp. 1501-1515
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Type 2 immunity in allergic diseases
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 6
Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Dose-dependent effects of Nrf2 on the epidermis in chronic skin inflammation
Michael Koch, Luca Ferrarese, Maya Ben‐Yehuda Greenwald, et al.
Disease Models & Mechanisms (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
José Miguel Alvarenga, Thomas Bieber, Tiago Torres
Drugs (2024)
Open Access | Times Cited: 6
Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
Kaidi Zhao, Yang Zhao, Shengxiang Xiao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Atopic Dermatitis (Eczema) Guidelines 2023: Highlights
Anna De Benedetto, Mark Boguniewicz, Peck Y. Ong, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2955-2965
Closed Access | Times Cited: 4
A phase 2, randomized, double‐blind, vehicle‐controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis
Atsuyuki Igarashi, Gaku Tsuji, Ryusei Murata, et al.
The Journal of Dermatology (2024)
Open Access | Times Cited: 4
Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights
Heidi M. Abdel-Mageed
Inflammopharmacology (2025)
Open Access
Just scratching the surface: A review of pediatric skin allergies
Mary Grace Baker, Lara S. Ford, Dianne E. Campbell, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 2
Closed Access
Systemtherapie der AD
Thomas Werfel
hautnah dermatologie (2025) Vol. 41, Iss. S1, pp. 6-15
Closed Access
Comparative efficacy and safety of dupilumab versus newly approved biologics and JAKi in pediatric atopic dermatitis: A systematic review and network meta-analysis
Qiwei Liao, Hong Pan, Yixin Guo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319400-e0319400
Open Access
Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis
Richard B. Warren, Anne Weiss, Jakob Felding, et al.
Dermatology and Therapy (2025)
Open Access
Patient Needs and Treatment Goals in Chronic Atopic Pruritus: Does Eczema Make a Difference?
Svenja Müller, Claudia Zeidler, Christian Meß, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42773-adv42773
Open Access
Disease burden and treatment preference for moderate‐to‐severe atopic dermatitis in Taiwan: A discrete‐choice experiment
Yung‐Tsu Cho, H.P. Chou, Tom C. Chan, et al.
The Journal of Dermatology (2025)
Closed Access
Difamilast Topically Ameliorates Pruritus, Dermatitis, and Barrier Dysfunction in Atopic Dermatitis Model Mice by Inhibiting Phosphodiesterase 4, Especially the 4B Subtype.
Kazuyoshi Kirima, Yukio Hoshino, Naoya Arichika, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103582-103582
Closed Access
Chronic hand eczema treatment: exploring topical JAK inhibition further
Yael Renert‐Yuval
The Lancet (2025)
Closed Access
Head and neck dermatitis: a variant of atopic dermatitis
Leszek Blicharz, Agnieszka Michalczyk, Małgorzata Maj, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 160, Iss. 2
Closed Access
Changes in Childhood Atopic Dermatitis Incidence and Risk Factors Over Time: Results From Two German Birth Cohorts
Zhuoxin Peng, Linda P. Siziba, Hermann Brenner, et al.
Clinical & Experimental Allergy (2025)
Open Access
An updated reappraisal of dupilumab in children and adolescents with moderate–severe atopic dermatitis
Giorgio Ciprandi, Amelia Licari, Maria Angela Tosca, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 6
Closed Access | Times Cited: 2
Pharmacological Trends in the Management of Atopic Dermatitis: A Comprehensive Review
Drishti M Bhatt, Adarshlata Singh, Bhushan Madke, et al.
Cureus (2024)
Open Access | Times Cited: 2
Neutrophils in Atopic Dermatitis
Chih-Chao Chiang, Wei-Jen Cheng, Joseph Renz Marion Santiago Dela Cruz, et al.
Clinical Reviews in Allergy & Immunology (2024)
Open Access | Times Cited: 2
Atopic dermatitis: pathogenesis and therapeutic intervention
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
Laure Migayron, Sylvie Bordes, B. Closs, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Development and validation of an enzyme-linked immunosorbent assay for the quantification of a recombinant humanized anti-IL-4Rα monoclonal antibody CM310 in serum and its application to pharmacokinetic study in Sprague-Dawley Rats.
Yimeng Hao, Libo Zhang, Qinghe Meng, et al.
Analytical Biochemistry (2024) Vol. 694, pp. 115623-115623
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top